FDA clearance expands use of the INVOS™ 7100 system, helping clinicians better monitor organ-specific oxygen levels and identify warnings signs for neonates and children earlier "Timing is critical ...
(RTTNews) - Healthcare technology firm Medtronic plc (MDT) announced Tuesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its INVOS 7100 cerebral/somatic oximetry ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback